ViroSeq Gets FDA Clearance for use on ABI s 3700 DNA Analyzer | GenomeWeb

NEW YORK, June 25 - Celera Diagnostics today said that the US Food and Drug Administration has granted an additional marketing clearance for the company's ViroSeq HIV-1 genotyping system, a molecular diagnostic.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.